NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of…
TGTX jumps after preliminary 2025 sales beat guidance. Its bullish 2026 revenue target and multiple Briumvi pipeline milestones also draw…
TG Therapeutics stock rises after strong 2025 revenue and positive 2026 outlook…
…
Image source: The Motley Fool.DateNov. 3, 2025 at 11:56 a.m. ETCall participantsChief Executive Officer — Michael WeissChief Commercial Officer —…
…
Key PointsSold 21,000 shares of Check Point Software Technologies Ltd, an estimated $4.65 million trade in Q3 2025Post-trade stake: 0…
TG Therapeutics (TGTX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
TG Therapeutics slides 18% as second-quarter earnings fall short despite a 92% revenue jump fueled by surging Briumvi sales.…
TG Therapeutics (TGTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
…
…
A near-doubling of revenue and a flip into profitability on the bottom line apparently werent good enough for TG Therapeutics…
…
…
TG Therapeutics (TGTX) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Strong adoption of TGTXs sole marketed product, Briumvi, approved for treating relapsing forms of multiple sclerosis, is driving the top…
Multiple Sklerose (MS) ist eine chronische Erkrankung des zentralen Nervensystems, bei der die Schutzhülle der Nervenfasern nach und nach beschädigt…
TG Therapeutics (TGTX) saw its shares surge in the last session with trading volume being higher than average. The latest…
…
…
Following news of an estimates-topping fourth quarter, TG Therapeutics (NASDAQ: TGTX) stock was a hot item with investors over the…
Here’s what happened to TG Therapeutics.…
TG Therapeutics stock rises following upbeat Q4 earnings…
…
…
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions…
…
Presentation scheduled for Monday, January 13, 2025, at 4:30 PM PT Presentation scheduled for Monday, January 13, 2025, at 4:30…
Fireside chat scheduled for Tuesday, December 3, 2024, at 10:00 AM ET Fireside chat scheduled for Tuesday, December 3, 2024,…
…
TG Therapeutics Inc. (TGTX) ist ein biopharmazeutisches Unternehmen, das sich auf innovative Therapien zur Behandlung von Autoimmun- und Krebserkrankungen spezialisiert…
TG Therapeutics beschäftigt sich mit dem Erwerb, der Entwicklung und Vermarktung neuartiger Behandlungen für B-Zell-Malignome und Autoimmunerkrankungen. Das Unternehmen…
…
TG Therapeutics cruised past a 23.12 alternative entry.…
…
…
Fireside chat scheduled for Wednesday, June 5, 2024, at 1:30 PM ET Fireside chat scheduled for Wednesday, June 5, 2024,…
…
Earnings call: TG Therapeutics sees strong Q1 growth with Briumvi…
…
…
Conference call to be held tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET Conference call to be held tomorrow,…
NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of…
…
…